# ClinicalTrials.gov record NCT00191321

> PeptideScanner retained ClinicalTrials.gov record NCT00191321 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct00191321-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2007-01-26
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00191321-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00191321-teriparatide-v1.json
- Content SHA-256: `6f9b7805f4e0bfc5bcc7c8f63259c02d93651d4a713e50119794c2ba6f2387a1`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00191321 ([`ctg-observation-nct00191321-2007-01-26-228c4e2f78eb`](#source-ctg-observation-nct00191321-2007-01-26-228c4e2f78eb))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00191321 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00191321-2007-01-26-228c4e2f78eb`](#source-ctg-observation-nct00191321-2007-01-26-228c4e2f78eb))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00191321 at 2026-07-30T22:39:13.108Z. Its registry update date was 2007-01-26, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct00191321-2007-01-26-228c4e2f78eb`](#source-ctg-observation-nct00191321-2007-01-26-228c4e2f78eb))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00191321-2007-01-26-228c4e2f78eb`](#source-ctg-observation-nct00191321-2007-01-26-228c4e2f78eb))

## Sources

<a id="source-ctg-observation-nct00191321-2007-01-26-228c4e2f78eb"></a>
- **ClinicalTrials.gov record NCT00191321 · retained source version 2007-01-26:228c4e2f78eb1a51726fc8611f60932f956de18e76dfe18b2d0bb4ccd020f535** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00191321) (`ctg-observation-nct00191321-2007-01-26-228c4e2f78eb`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00191321." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00191321-teriparatide-v1.json SHA-256: 6f9b7805f4e0bfc5bcc7c8f63259c02d93651d4a713e50119794c2ba6f2387a1.